PTC Therapeutics, Inc. (PTCT)
63.33
-0.96
(-1.49%)
USD |
NASDAQ |
Mar 05, 16:00
63.31
-0.02
(-0.03%)
After-Hours: 20:00
PTC Therapeutics Cash from Investing (TTM) : -861.98M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | -414.24M |
| Sarepta Therapeutics, Inc. | 69.64M |
| Ardelyx, Inc. | -8.959M |
| Spyre Therapeutics, Inc. | -143.48M |
| Ovid Therapeutics, Inc. | 43.50M |